Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Albratty M. | |
dc.contributor.author | El-Sharkawy K.A. | |
dc.contributor.author | Alhazmi H.A. | |
dc.contributor.other | Department of Pharmaceutical Chemistry | |
dc.contributor.other | College of Pharmacy Jazan University | |
dc.contributor.other | P.O. Box 114 | |
dc.contributor.other | Jazan | |
dc.contributor.other | 45142 | |
dc.contributor.other | Saudi Arabia; Department of Organic Chemistry | |
dc.contributor.other | Faculty of Biotechnology October | |
dc.contributor.other | University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | El-Wahat Road | |
dc.contributor.other | 6 October City | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:40:37Z | |
dc.date.available | 2020-01-09T20:40:37Z | |
dc.date.issued | 2019 | |
dc.description | Scopus | |
dc.description.abstract | In an attempt to produce heterocyclic compounds based on 1,3,4-oxadiazole derivatives with potential antiviral activity, synthesis of compound 1 [2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile] was performed through the reaction of cyanoacetic acid hydrazide with carbon disulfide in alcoholic potassium hydroxide. Compound 1 has an activating methylene group, so it was directed toward some specific reactions. Thus, aryldiazonium chlorides reacted with compound 1 affording hydrazono derivatives 2a-c. Also, aromatic aldehydes reacted with compound 1 to produce compounds 3a,b. Furthermore, cyclic ketones were subjected to the synthesis of fused thiophene derivatives 4a,b via reaction with compound 1 in the presence of elemental sulfur. In addition, 1,3,4-oxadiazole derivative 1, when reacted with isothiocyanates, salicylaldehyde or 1,3-dicarbonyl compounds, formed thiazole derivatives 5a,b, coumarin derivative 6 and alkenyl derivatives 7a,b resp. Compound 7b underwent cyclization to afford pyridine derivative 8. Arylhydrazono derivatives 9a,b were produced through the reaction of compound 7a with aryldiazonium chlorides. Products 9a,b underwent cyclization to produce pyridazine derivatives 10a,b. Finally, 1,3,4-oxadiazole derivative 1 was directed toward reaction with hydrazine derivatives, bromoacetophenone and ethylchloroacetate affording compounds 11a,b, 12 and 13, resp. Fused thiophene derivatives 14a,b were produced via reaction of compounds 4a,b with a mixture of malononitrile and ethylorthoformate. Antiviral activity of the synthesized products showed that 5-(4-amino-3-ethyl-2-thioxo-2,3-dihydrothiazol-5-yl)-1,3,4-oxadiazole-2(3H)-thione (5a) and 5-(4-amino-3-phenyl-2-thioxo-2,3-dihydrothiazol-5-yl)-1,3,4-oxadiazole-2(3H)-thione (5b) acted as the most active agents against Feline herpes virus, Feline corona virus, Herpes simplex virus-1 and Herpes simplex virus-2, whereas compound 2-(5-(2-phenylhydrazono)-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile (11b) was the most effective against Vaccinia virus, Herpes simplex virus (TK-KOS-ACVr), Coxsackie virus B4 and Vesicular stomatitis virus. 2019 Mohammed Albratty et al., published by Sciendo 2019. | en_US |
dc.identifier.doi | https://doi.org/10.2478/acph-2019-0015 | |
dc.identifier.doi | PubMedID31259726 | |
dc.identifier.issn | 13300075 | |
dc.identifier.other | https://doi.org/10.2478/acph-2019-0015 | |
dc.identifier.other | PubMedID31259726 | |
dc.identifier.uri | https://t.ly/7y8l2 | |
dc.language.iso | English | en_US |
dc.publisher | Sciendo | en_US |
dc.relation.ispartofseries | Acta Pharmaceutica | |
dc.relation.ispartofseries | 69 | |
dc.subject | 1,3,4-oxadiazole derivatives | en_US |
dc.subject | antiviral activity | en_US |
dc.subject | coumarin | en_US |
dc.subject | pyridazine | en_US |
dc.subject | pyridine | en_US |
dc.subject | thiazole | en_US |
dc.subject | thiophene | en_US |
dc.subject | 1 (1 (4 chlorophenyl) 6 imino 4 methyl 5 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl) 1 6 dihydropyridazin 3 yl)ethanone | en_US |
dc.subject | 1 (6 imino 4 methyl 1 phenyl 5 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl) 1 6 dihydropyridazin 3 yl) ethanone | en_US |
dc.subject | 1,3,4 oxadiazole derivative | en_US |
dc.subject | 2 ((2 (5 thioxo 4,5 dihydro 1,3,4 oxadiazol 2 yl) 4.5,6,7 tetrahydrobenzo [b] thiophen 3 ylimino)methyl)malononitrile | en_US |
dc.subject | 2 ((2 (5 thioxo 4,5 dihydro 1,3,4 oxadiazol 2 yl) 5,6 dihydro 4h cyclopenta[b] thiophen 3 yl imino)methyl)malononitrile | en_US |
dc.subject | 2 (5 (2 oxo 2 phenylethylthio) 1 3 4 oxadiazol 2 yl)acetonitrile | en_US |
dc.subject | 2 (5 (2 phenyl hydrazono) 4 5 dihydro 1 3 4 oxadiazol 2 yl)acetonitrile | en_US |
dc.subject | 2 (5 hydrazono 4 5 dihydro 1 3 4 oxadiazol 2 yl)acetonitrile | en_US |
dc.subject | 2 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)acetonitrile | en_US |
dc.subject | 3 (4 chlorophenyl) 2 (5 thioxo 4 5 dihydro1 3 4 oxadiazol 2 yl)acrylonitrile | en_US |
dc.subject | 3 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl) 2h chromen 2 one | en_US |
dc.subject | 3 methyl 5 oxo 2 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)hex 2 enenitrile | en_US |
dc.subject | 3 methyl 5 oxo 4 (2 phenylhydrazono) 2 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)hex 2 enenitrile | en_US |
dc.subject | 3 phenyl 2 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)acrylonitrile | en_US |
dc.subject | 4 (2 (4 chlorophenyl)hydrazono) 3 methyl 5 oxo 2 (5 thioxo 4 5 dihydro1 3 4 oxadiazol 2 yl)hex 2 enenitrile | en_US |
dc.subject | 4 cyano 3 methyl n phenyl 4 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)but 3 enamid | en_US |
dc.subject | 5 (3 amino 4 5 6 7 tetrahydrobenzo[b]thiophen 2 yl) 1 3 4 oxadiazole 2(3h) thione | en_US |
dc.subject | 5 (3 amino 5 6 dihydro 4h cyclopenta[b]thiophen 2 yl) 1 3 4 oxadiazole 2(3h) thione | en_US |
dc.subject | 5 (4 amino 3 ethyl 2 thioxo 2 3 dihydrothiazol 5 yl) 1 3 4 oxadiazole 2(3h) thione | en_US |
dc.subject | 5 (4 amino 3 phenyl 2 thioxo 2 3 dihydrothiazol 5 yl) 1 3 4 oxadiazole 2(3h) thione | en_US |
dc.subject | 6 amino 4 methyl 1 phenyl 5 (5 thioxo 4 5 dihydro 1 3 4 oxadiazol 2 yl)pyridin 2(1h) one | en_US |
dc.subject | aciclovir | en_US |
dc.subject | cidofovir | en_US |
dc.subject | ethyl 2 (5 (cyanomethyl) 1 3 4 oxadiazol 2 ylthio)acetate | en_US |
dc.subject | ganciclovir | en_US |
dc.subject | n (4 chlorophenyl) 5 thioxo 4 5 dihydro 1 3 4 oxadiazole 2 carbohydrazonoyl cyanide | en_US |
dc.subject | n (4 methoxyphenyl) 5 thioxo 4 5 dihydro1 3 4 oxadiazole 2 carbohydrazonoyl cyanide ( | en_US |
dc.subject | n phenyl 5 thioxo 4 5 dihydro 1 3 4 oxadiazole 2 carbohydrazonoyl cyanide | en_US |
dc.subject | ribavirin | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | 1,3,4-oxadiazole | en_US |
dc.subject | antivirus agent | en_US |
dc.subject | oxadiazole derivative | en_US |
dc.subject | antiviral activity | en_US |
dc.subject | Article | en_US |
dc.subject | carbon nuclear magnetic resonance | en_US |
dc.subject | controlled study | en_US |
dc.subject | Coxsackievirus B4 | en_US |
dc.subject | cytopathogenic effect | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | Feline coronavirus | en_US |
dc.subject | Herpes simplex virus | en_US |
dc.subject | Herpes simplex virus 2 | en_US |
dc.subject | Herpesviridae | en_US |
dc.subject | human | en_US |
dc.subject | Human alphaherpesvirus 1 | en_US |
dc.subject | human cell | en_US |
dc.subject | infrared spectroscopy | en_US |
dc.subject | mass spectrometry | en_US |
dc.subject | melting point | en_US |
dc.subject | proton nuclear magnetic resonance | en_US |
dc.subject | quantitative structure activity relation | en_US |
dc.subject | Vaccinia virus | en_US |
dc.subject | Vesiculovirus | en_US |
dc.subject | chemistry | en_US |
dc.subject | drug effect | en_US |
dc.subject | structure activity relation | en_US |
dc.subject | synthesis | en_US |
dc.subject | virus | en_US |
dc.subject | Antiviral Agents | en_US |
dc.subject | Oxadiazoles | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.subject | Viruses | en_US |
dc.title | Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Desai, N.C., Somani, H., Trivedi, A., Bhatt, K., Nawale, L., Khedkar, V.M., Jha, P.C., Sarkar, D., Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1, 3, 4-oxadiazole derivatives as potential antitubercular agents (2016) Bioorg. Med. Chem. Lett., 26, pp. 1776-1783. , https://doi.org/10.1016/j.bmcl.2016.02.043; Banerjee, A.G., Das, N., Shengule, S.A., Srivastava, R.S., Shrivastava, S.K., Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1, 2, 4-triazin-3(2H)-one derivatives bearing 5-substituted 1, 3, 4-oxadiazole as potential anti-inflammatory and analgesic agents (2015) Eur. J. Med. Chem., 101, pp. 81-95. , https://doi.org/10.1016/j.ejmech.2015.06.020; Wu, W., Chen, Q., Tai, A., Jiang, G., Ouyang, G., Synthesis and antiviral activity of 2-substituted methylthio-5-(4-amino-2-methylpyrimidin-5-yl)-1, 3, 4-oxadiazole derivatives (2015) Bioorg. Med. Chem. Lett., 25, pp. 2243-2246. , https://doi.org/10.1016/j.bmcl.2015.02.069; Zhang, S., Luo, Y., He, L.Q., Liu, Z.J., Jiang, A.Q., Yang, Y.H., Zhu, H.L., Synthesis, biological evaluation, and molecular docking studies of novel 1, 3, 4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity (2013) Bioorg. Med. Chem., 21, pp. 3723-3729. , https://doi.org/10.1016/j.bmc.2013.04.043; Rane, R.A., Gutte, S.D., Sahu, N.U., Synthesis and evaluation of novel 1, 3, 4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent (2012) Bioorg. Med. Chem. Lett., 22, pp. 6429-6432. , https://doi.org/10.1016/j.bmcl.2012.08.061; Kotaiah, Y., Harikrishna, N., Nagaraju, K., Rao, C.V., Synthesis and antioxidant activity of 1, 3, 4-oxadiazole tagged thieno[2, 3-d]pyrimidine derivatives (2012) Eur. J. Med. Chem., 58, pp. 340-345. , https://doi.org/10.1016/j.ejmech.2012.10.007; Desai, N.C., Bhatt, N., Somani, H., Trivedi, A., Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1, 3, 4-oxadiazoles (2013) Eur. J. Med. Chem., 67, pp. 54-59. , https://doi.org/10.1016/j.ejmech.2013.06.029; Mahesh, M., Bheemaraju, G., Manjunath, G., Ramana, P.V., Synthesis of new oxadiazole, pyrazole and pyrazolin-5-one bearing 2-(4-methyl-2-oxo-2H-chromen-7-yl)oxy) acetohydrazide analogs as potential antibacterial and antifungal agents (2016) Ann. Pharm. Fran., 74, pp. 34-44. , https://doi.org/10.1016/j.pharma.2015.07.002; Wu, J., Song, B., Chen, H., Bhadury, P., Hu, D., Synthesis and antifungal activity of 5-chloro-6-phenylpyridazin-3(2H)-one derivatives (2009) Molecules, 14, pp. 3676-3687. , https://doi.org/10.3390/molecules14093676; Chaves, J.D.S., Tunes, L.G., De J Franco, C.H., Francisco, T.M., Corr�a, C.C., Murta, S.M.F., Monte-Neto, R.L., De Almeida, M.V., Novel gold(I) complexes with 5-phenyl-1, 3, 4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents (2017) Eur. J. Med. Chem., 127, pp. 727-739. , https://doi.org/10.1016/j.ejmech.2016.10.052; Puthiyapurayil, P., Poojary, B., Chikkanna, C., Buridipad, S.K., Design, synthesis and biological evaluation of a novel series of 1, 3, 4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents (2012) Eur. J. Med. Chem., 53, pp. 203-210. , https://doi.org/10.1016/j.ejmech.2012.03.056; Bansal, S., Bala, M., Suthar, S.K., Choudhary, S., Bhattacharya, S., Bhardwaj, V., Singla, S., Joseph, A., Design and synthesis of novel 2-phenyl-5-(1, 3-diphenyl-1H-pyrazol-4-yl)-1, 3, 4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity (2014) Eur. J. Med. Chem., 80, pp. 167-174. , https://doi.org/10.1016/j.ejmech.2014.04.045; Desai, S.R., Laddi, U., Bennur, R.S., Patil, P.A., Bennur, S., Synthesis and pharmacological activities of some new 5-substituted-2-mercapto-1, 3, 4-oxadiazoles (2011) Indian J. Pharm. Sci., 73, pp. 593-596. , https://doi.org/10.4103/0250-474X.99025; De Clercq, E., Sakuma, T., Baba, M., Pauwels, R., Balzarini, J., Rosenberg, I., Holy, A., Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines (1987) Antiviral Res., 8, pp. 261-272. , https://doi.org/10.1016/S0166-3542(87)80004-9; El-Sharkawy, K.A., El-Sayed, N.N.E., Zaki, M.Y., Uses of 2-amino-5, 6-dihydro-4H-cyclopenta-[b]thiophene-3-carbonitrile in the synthesis of heterocyclic compounds with anticonvulsant, behavioral and CNS antidepressant activities (2012) Int. Res. J. Pure Appl. Chem., 2, pp. 91-104. , https://doi.org/10.9734/IRJPAC/2012/1222; Albratty, M., El-Sharkawy, K.A., Alam, M.S., Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives (2017) Acta Pharm., 67, pp. 15-33. , https://doi.org/10.1515/acph-2017-0004 | |
dcterms.source | Scopus |